This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, S M
Right arrow Articles by Eng, R H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, S M
Right arrow Articles by Eng, R H

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 May; 27(5): 688-691

Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.

S M Smith and R H Eng

ABSTRACT

Ciprofloxacin, a carboxy quinolone antibiotic with a broad spectrum of activity, was tested against 54 strains of methicillin-resistant Staphylococcus aureus. The ciprofloxacin MICs for 50 and 90% of the isolates were 0.25 and 0.5 micrograms/ml, respectively, and its MBC for 90% of the isolates was 1.0 microgram/ml. Killing kinetic studies were conducted in vitro with ciprofloxacin and vancomycin individually and in combination. The results of these studies showed that ciprofloxacin at 2 micrograms/ml and vancomycin at 10 micrograms/ml decreased the number of organisms by approximately 1.5 log10 after 6 h. The combination of ciprofloxacin plus vancomycin did not alter the rate of killing over that achieved by ciprofloxacin alone. The in vitro killing of resistant staphylococci was rapid, and the potential use of ciprofloxacin for infections caused by methicillin-resistant S. aureus should be further explored.


Antimicrob Agents Chemother. 1985 May; 27(5): 688-691




This article has been cited by other articles:

  • Landersdorfer, C. B., Kinzig, M., Hennig, F. F., Bulitta, J. B., Holzgrabe, U., Drusano, G. L., Sorgel, F., Gusinde, J. (2009). Penetration of Moxifloxacin into Bone Evaluated by Monte Carlo Simulation. Antimicrob. Agents Chemother. 53: 2074-2081 [Abstract] [Full Text]  
  • O'Brien, T. P., Maguire, M. G., Fink, N. E., Alfonso, E., McDonnell, P., Bacterial Keratitis Study Research Group, (1995). Efficacy of Ofloxacin vs Cefazolin and Tobramycin in the Therapy for Bacterial Keratitis: Report From the Bacterial Keratitis Study Research Group. Arch Ophthalmol 113: 1257-1265 [Abstract]  
  • Trucksis, M., Hooper, D. C., Wolfson, J. S. (1991). Emerging Resistance to Fluoroquinolones in Staphylococci: An Alert. ANN INTERN MED 114: 424-426 [Abstract]